This inventor holds 5 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Unversität Zürich. Active years: 2013-2023.
Location History:
- Ontario, CA (2013)
- Toronto, CA (2016 - 2023)
Company Filing History:
Years Active: 2013-2023
Title: Dimitri Peter Fitsialos: Innovator in Cancer Treatment
Introduction
Dimitri Peter Fitsialos is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cancer treatment, holding a total of 5 patents. His work focuses on innovative methods for preventing and treating various types of cancer, particularly head and neck squamous cell cancer and bladder cancer.
Latest Patents
One of his latest patents involves an immunotoxin designed for treating cancer. This invention relates to methods that utilize a ligand that binds to a protein on the cancer cell, which is attached to a toxin that is cytotoxic to the cancer cell. Specifically, the invention targets head and neck squamous cell cancer or bladder cancer using Vb4-845, a recombinant immunotoxin that comprises a humanized, MOC31-derived, single-chain antibody fragment fused to a truncated form of exotoxin A. The patent also encompasses combination therapy methods, which include the use of reduced dosages of chemotherapeutic agents for the prevention or treatment of cancer. Additionally, it covers formulations and methods for the direct administration of the recombinant immunotoxin to the carcinoma.
Career Highlights
Dimitri has worked with prestigious institutions, including the University of Zurich. His experience in these environments has contributed to his innovative research and development in cancer therapies.
Collaborations
Throughout his career, Dimitri has collaborated with notable colleagues such as Uwe Zangemeister-Wittke and Claudio Di Paolo. These partnerships have further enhanced his research efforts and the impact of his inventions.
Conclusion
Dimitri Peter Fitsialos is a pioneering inventor whose work in cancer treatment is making a significant difference in the medical field. His innovative approaches and collaborations continue to advance the fight against cancer.